Chemical Compound

4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-; N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide; N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide; RAL; Raltegravir

CAS Registry Number 518048-05-0
4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-; N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide; N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide; RAL; Raltegravir 结构式
Primary record

4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-; N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide; N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide; RAL; Raltegravir

库存
9,007 克
纯度
98.7 %
CAS
518048-05-0

化合物标识与属性

CAS
518048-05-0
PubChem CID
54671008
SMILES
CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F
Canonical SMILES
Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1

名称与同义词

  • Raltegravir
  • Isentress
  • 518048-05-0
  • raltegravirum
  • Raltegravir (MK-0518)
  • MK-0518
  • Isentress(TM)
  • Raltegravir?
  • Raltegravir potassium
  • N-oleoyl glycine
  • Raltegravir (INN)
  • Raltegravir [USAN]
  • Raltegravir [USAN:INN]
  • RefChem:55964
  • MK0518
  • Raltegravir [INN:BAN]
  • RALTEGRAVIR [MI]
  • RALTEGRAVIR [INN]
  • Raltegravir(MK-0518)
  • Raltegravir; MK-0518
  • Raltegravir Potassium Salt
  • DTXSID2048660
  • CHEBI:82960
  • D0I1FQ
  • Epitope ID:231726
  • RALTEGRAVIR [VANDF]
  • UNII-22VKV8053U
  • Raltegravir - MK-0518
  • Raltegravir(MK-0518)/
  • 22VKV8053U
  • RALTEGRAVIR [MART.]
  • hydropyrimidine-4-carboxamide
  • SCHEMBL51817
  • DTXCID5028586
  • RALTEGRAVIR [WHO-DD]
  • C20H21FN6O5
  • cc-110
  • HSDB 8124
  • MLS006011985
  • (2-Methoxy-phenyl)-hydrazine
  • SCHEMBL996804
  • MK 0518
  • MFCD10698872
  • RALTEGRAVIR [EMA EPAR]
  • CHEMBL254316
  • orb1305950
  • SCHEMBL2112870
  • Raltegravir - Bio-X trade mark
  • BDBM25351
  • GTPL11571
  • KS-00000XJN
  • J05AX08
  • CZFFBEXEKNGXKS-UHFFFAOYSA-N
  • BCPP000093
  • GLXC-90212
  • HMS3655B09
  • HMS5080N13
  • 518048-05-0 (free)
  • AOB87131
  • BCP01394
  • EX-A2147
  • Tox21_113019
  • ABP000913
  • EBC-07544
  • MFCD12031642
  • MK-518
  • NCGC00184997-01
  • NSC762522
  • s2005
  • ZINC13831130
  • N-(2-(4-(4-fluorobenzylcarbamoyl)
  • AKOS015902444
  • AKOS025149884
  • AKOS032960305
  • N-(2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
  • Tox21_113019_1
  • ZINC114994525
  • AC-5261
  • ACN-046772
  • AN-3529
  • CCG-269170
  • CS-2396
  • CS-O-11731
  • DB06817
  • FR29048
  • NSC-762522
  • PB13312
  • SB20935
  • 871038-72-1
  • CID11598201
  • CID11700929
  • NCGC00274066-01
  • NCGC00274066-05
  • 0518, MK
  • AK326327
  • AS-16992
  • BC228658
  • BR164312
  • CJ-14473
  • HY-10353
  • SC-69059
  • SMR003601806
  • K-0518
  • AB0028054
  • AB1004864
  • TL8006542
  • 2450A
  • A4073
  • CAS-518048-05-0
  • FT-0649660
  • L000900612
  • NS00015450
  • SW220138-1
  • X0050
  • J2.509.696G
  • L-000900612
  • D06676
  • D07133
  • EN300-120882
  • MK-0518;MK 0518;MK0518
  • Q-4458
  • yl}-6-oxo-1,6-dihydropyrimidine-4-carboxamide
  • AB01566833_01
  • N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
  • 038R721
  • 048R050
  • A828788
  • Q421552
  • 4-Pyrimidinecarboxamide, N-((4-fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-
  • I14-1973
  • N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-yl}-6-oxo-1,6-dihydropyrimidine-4-carboxamide
  • BRD-K05658747-001-02-9
  • BRD-K05658747-001-03-7
  • BRD-K05658747-237-01-1
  • [(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-
  • N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
  • N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-{2-
  • Z1532717445
  • N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide
  • RAL
  • 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133
  • N-[1-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxo-pyrimidin-2-yl]-1-methyl-ethyl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
  • RGV
  • 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-; N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide; N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide; RAL; Raltegravir
  • N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo -4-pyrimidinecarboxamide
  • N-(2-(4-((4-fluorophenyl)methylcarbamoyl)-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
  • N-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidin-2-yl)propan-2-yl) -5-methyl-1,3,4-oxadiazole-2- carboxamide
  • N-(2-(4-(4-FLUOROBENZYLCARBAMOYL)-5-HYDROXY-1-METHYL-6-OXO-1,6- DIHYDROPYRIMIDIN-2-YL)PROPAN-2-YL)-5-METHYL-1,3,4-OXADIAZOLE-2-CARBOXAMIDE
  • N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-OH-1-Me-6-oxo-pyrimidin-2-yl)propan-2-yl)-5-Me-1,3,4-oxadiazole-2-carboxamide
  • N-(4-Fluorobenzyl)-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-yl)carbonylamino]ethyl]-6-oxo-4-pyrimidinecarboxamide
  • N-(4-Fluorobenzyl)-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-yl)carbonylamino]ethyl]-6-oxopyrimidine-4-carboxamide
  • N-(4-FLUOROBENZYL)-5-HYDROXY-1-METHYL-2-(1-METHYL-1-(((5-METHYL-1,3,4-OXADIAZOL-2-YL)CARBONYL)AMINO)ETHYL)-6-OXO-1,6-DIHYDROPYRIMIDINE-4-CARBOXAMIDE
  • N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-di
  • N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-di hydropyrimidine-4-carboxamide
  • N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}propan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide
  • N-[(4-Fluorophenyl)methyl]-5-hydroxy-1-methyl-2-[2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide
  • N-[1-[(4Z)-4-[[(4-fluorophenyl)methylamino]-hydroxy-methylene]-1-methyl-5,6-dioxo-pyrimidin-2-yl]-1-methyl-ethyl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
  • N-[2-(4-{[(4-fluorophenyl)methyl]carbamoyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
  • N-{2-[(4Z)-4-({[(4-FLUOROPHENYL)METHYL]AMINO}(HYDROXY)METHYLIDENE)-1-METHYL-5,6-DIOXOPYRIMIDIN-2-YL]PROPAN-2-YL}-5-METHYL-1,3,4-OXADIAZOLE-2-CARBOXAMIDE
  • RLT